Z-Pak



Indications and Reactions:

Role Indications Reactions
Primary
Bronchitis 33.3%
Pharyngitis Streptococcal 33.3%
Sinusitis 33.3%
Atrial Flutter 12.5%
Heart Rate Increased 12.5%
Jaundice 12.5%
Malaise 12.5%
Neuropathy Peripheral 12.5%
Palpitations 12.5%
Tinnitus 12.5%
Vomiting 12.5%
Secondary
Bronchitis 12.5%
Product Used For Unknown Indication 12.5%
Hypersensitivity 10.0%
Nasopharyngitis 10.0%
Foetal Exposure During Pregnancy 7.5%
Drug Use For Unknown Indication 5.0%
Hiv Infection 5.0%
Sinus Disorder 5.0%
Type 2 Diabetes Mellitus 5.0%
Anxiety 2.5%
Crohn's Disease 2.5%
Depression 2.5%
Diarrhoea 2.5%
Herpes Simplex 2.5%
Hypogammaglobulinaemia 2.5%
Insomnia 2.5%
Irritable Bowel Syndrome 2.5%
Pain 2.5%
Pain Management 2.5%
Sinus Operation 2.5%
Drug Hypersensitivity 10.5%
Sinus Disorder 10.5%
Anosmia 5.3%
Dizziness 5.3%
Drug Dispensing Error 5.3%
Loss Of Consciousness 5.3%
Nasopharyngitis 5.3%
Otitis Media Chronic 5.3%
Respiratory Arrest 5.3%
Sinus Headache 5.3%
Sinusitis 5.3%
Therapeutic Product Ineffective 5.3%
Thinking Abnormal 5.3%
Thrombosis 5.3%
Urticaria 5.3%
Vomiting 5.3%
Weight Decreased 5.3%
Concomitant
Drug Use For Unknown Indication 33.8%
Product Used For Unknown Indication 12.4%
Multiple Myeloma 7.2%
Pain 6.9%
Contraception 3.9%
Anxiety 3.2%
Asthma 3.0%
Foetal Exposure During Pregnancy 3.0%
Prophylaxis 3.0%
Depression 2.8%
Bronchitis 2.6%
Sinusitis 2.6%
Upper Respiratory Tract Infection 2.5%
Headache 2.3%
Anaesthesia 2.2%
Plasma Cell Myeloma 1.9%
Cough 1.7%
Hypertension 1.7%
Migraine 1.7%
Muscle Spasms 1.5%
Pulmonary Embolism 26.6%
Pain 10.9%
Weight Decreased 6.3%
Weight Increased 6.3%
Pneumonia 5.5%
Vomiting 4.7%
Deep Vein Thrombosis 3.9%
Sinusitis 3.9%
Pulmonary Infarction 3.1%
Soft Tissue Infection 3.1%
Thrombophlebitis Superficial 3.1%
Vertigo 3.1%
Wound 3.1%
Sternal Fracture 2.3%
Thrombocytopenia 2.3%
Thrombosis 2.3%
Upper Respiratory Tract Infection 2.3%
Urinary Tract Infection 2.3%
Urticaria 2.3%
Wheezing 2.3%
Interacting
Infection 33.3%
Liver Transplant 33.3%
Upper Respiratory Tract Infection 33.3%
Drug Interaction 50.0%
Upper Respiratory Tract Infection 50.0%